THERAPEUTIC DRUG-MONITORING IN PSYCHIATRY

被引：5

作者：

GRAM, LF

机构：

[1] Department of Clinical Pharmacology, IMB, Odense University, Odense, DK-5000

来源：

CNS DRUGS | 1995年 / 4卷 / 06期

关键词：

D O I：

10.2165/00023210-199504060-00007

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：454 / 455

页数：2

共 13 条

[1] ASSOCIATION BETWEEN CLOZAPINE RESPONSE AND ALLELIC VARIATION IN 5HT(2A) RECEPTOR GENE [J].

ARRANZ, M ;

COLLIER, D ;

SODHI, M ;

BALL, D ;

ROBERTS, G ;

PRICE, J ;

SHAM, P ;

KERWIN, R .

LANCET, 1995, 346 (8970) :281-282

[2]

BALDESSARINI RJ, 1993, CLIN PHARM PSYCHIATR, P138

[3] CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM [J].

BROSEN, K ;

GRAM, LF .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :537-547

[4] COMPARISON OF STANDARD AND LOW SERUM LEVELS OF LITHIUM FOR MAINTENANCE TREATMENT OF BIPOLAR DISORDER [J].

GELENBERG, AJ ;

KANE, JM ;

KELLER, MB ;

LAVORI, P ;

ROSENBAUM, JF ;

COLE, K ;

LAVELLE, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1489-1493

[5]

GRAM LF, 1994, NEW ENGL J MED, V331, P1354

[6] PLASMA-LEVEL MONITORING OF TRICYCLIC ANTIDEPRESSANT THERAPY [J].

GRAM, LF .

CLINICAL PHARMACOKINETICS, 1977, 2 (04) :237-251

[7]

Hansen LB, 1983, CLIN PHARM PSYCHIATR, P175, DOI [10.1007/978-1-349-06671-1_16, DOI 10.1007/978-1-349-06671-1_16]

[8] THE USE OF THERAPEUTIC DRUG-MONITORING DATA TO DOCUMENT KINETIC DRUG-INTERACTIONS - AN EXAMPLE WITH AMITRIPTYLINE AND NORTRIPTYLINE [J].

JERLING, M ;

BERTILSSON, L ;

SJOQVIST, F .

THERAPEUTIC DRUG MONITORING, 1994, 16 (01) :1-12

[9]

Kjeldsen C S, 1991, Ugeskr Laeger, V153, P2339

[10] THE RELATIONSHIP BETWEEN SERUM LITHIUM LEVELS AND CLINICAL-RESPONSE [J].

SASHIDHARAN, SP .

THERAPEUTIC DRUG MONITORING, 1982, 4 (03) :249-264

← 1 2 →